Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

COTY

Coty Inc

Apr 26 • 01:42PM ET

11.51

Dollar change +0.09
Percentage change 0.83	%

Consumer Defensive • Household & Personal Products • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IJH VB VBR VXF IJK VDC DFAT IWR SCHM

Index	-	P/E	33.26	EPS (ttm)	0.35	Insider Own	56.06%	Shs Outstand	852.80M	Perf Week	3.27%
Market Cap	10.31B	Forward P/E	20.33	EPS next Y	0.57	Insider Trans	-0.03%	Shs Float	393.36M	Perf Month	-2.58%
Income	310.60M	PEG	1.82	EPS next Q	0.06	Inst Own	43.32%	Short Float	5.04%	Perf Quarter	-5.31%
Sales	6.01B	P/S	1.72	EPS this Y	-15.95%	Inst Trans	-1.29%	Short Ratio	4.84	Perf Half Y	19.08%
Book/sh	4.94	P/B	2.33	EPS next Y	27.17%	ROA	2.54%	Short Interest	19.84M	Perf Year	-1.24%
Cash/sh	0.54	P/C	21.32	EPS next 5Y	18.30%	ROE	8.14%	52W Range	9.02 - 13.46	Perf YTD	-7.29%
Dividend Est.	0.09 (0.75%)	P/FCF	29.74	EPS past 5Y	-	ROI	3.65%	52W High	-14.45%	Beta	1.83
Dividend TTM	-	Quick Ratio	0.58	Sales past 5Y	-8.13%	Gross Margin	60.48%	52W Low	27.73%	ATR (14)	0.35
Dividend Ex-Date	Feb 14, 2020	Current Ratio	0.85	EPS Y/Y TTM	145.74%	Oper. Margin	10.74%	RSI (14)	51.74	Volatility	3.36% 3.17%
Employees	11350	Debt/Eq	0.94	Sales Y/Y TTM	14.07%	Profit Margin	5.17%	Recom	2.05	Target Price	13.42
Option/Short	Yes / Yes	LT Debt/Eq	0.92	EPS Q/Q	-27.36%	Payout	0.00%	Rel Volume	0.20	Prev Close	11.42
Sales Surprise	2.89%	EPS Surprise	28.14%	Sales Q/Q	13.39%	Earnings	Feb 07 AMC	Avg Volume	4.10M	Price	11.51
SMA20	2.86%	SMA50	-3.29%	SMA200	-0.03%	Trades		Volume	532,314	Change	0.83%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-16-24	Reiterated	Citigroup	Neutral	$13 → $12
Apr-15-24	Initiated	Canaccord Genuity	Buy	$14
Feb-22-24	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $16
Oct-17-23	Initiated	TD Cowen	Market Perform	$11
Oct-10-23	Initiated	Kepler	Hold	$11.66
Jul-27-23	Downgrade	Jefferies	Buy → Hold	$16 → $14
Feb-17-23	Initiated	Citigroup	Neutral	$15
Jan-03-23	Upgrade	Piper Sandler	Neutral → Overweight	$8 → $10
Sep-22-22	Reiterated	Piper Sandler	Neutral	$9 → $10
Sep-14-22	Resumed	BofA Securities	Buy	$12
Jun-30-22	Initiated	Piper Sandler	Neutral	$8
Jan-21-22	Upgrade	DA Davidson	Neutral → Buy
Nov-17-21	Upgrade	Wells Fargo	Underweight → Equal Weight	$8 → $11
Nov-09-21	Upgrade	Raymond James	Mkt Perform → Outperform	$14
Oct-26-21	Upgrade	Deutsche Bank	Hold → Buy	$11
Jul-14-21	Initiated	Raymond James	Mkt Perform
Feb-10-21	Upgrade	Evercore ISI	In-line → Outperform
Dec-08-20	Downgrade	Wells Fargo	Equal Weight → Underweight	$4 → $5
Nov-19-20	Upgrade	Citigroup	Neutral → Buy	$4.50 → $10
Oct-07-20	Upgrade	Jefferies	Hold → Buy	$4

Show Previous Ratings

Apr-25-24 02:39PM	Infiniment Coty Paris Celebrated Libertys Launch With an Art Lovers Soirée (WWD)
Apr-20-24 01:37PM	20 Iconic Wedding Fragrances for Brides (Insider Monkey)
01:05PM	15 Best Everyday Colognes in 2024 (Insider Monkey)
Apr-12-24 03:12PM	Sally Hansen Names Duke University Basketball Star Jared McCain as New Brand Ambassador (Business Wire)
01:40AM	2023 Top 100: Coty Inc.s Turnaround Well Underway with 14 Percent Sales Boost (WWD)
05:25PM	Loading…
Apr-09-24 05:25PM	Sephora, Ulta, and e.l.f. among the top beauty brands for US teens, per survey (Yahoo Finance)
Apr-08-24 05:16AM	Personal Care Stocks Q4 Teardown: Coty (NYSE:COTY) Vs The Rest (StockStory)
Apr-07-24 08:00AM	Serena Williams Launches WYN Beauty, Joining Ranks of Celebrity Makeup Entrepreneurs (Investopedia)
Apr-03-24 02:59PM	Ulta Beauty Warning Weighs on Cosmetics Stocks (The Wall Street Journal) -6.28%
03:32AM	20 Best Fresh Colognes For Men in 2024 (Insider Monkey)
Mar-30-24 05:50AM	30 Best Colognes for Teenage Boys in 2024 (Insider Monkey)
Mar-29-24 07:50PM	20 Best Luxury Hotel Scents to Make Your Home Smell Like a 5-Star Hotel (Insider Monkey)
06:01AM	25 Most Expensive Fragrances in the World for Ladies (Insider Monkey)
Mar-28-24 04:41PM	25 Best Spring Fragrances for Men to Try in 2024 (Insider Monkey)
04:31PM	25 Best Everyday Colognes for Men in 2024 (Insider Monkey)
03:29PM	Loading…
03:29PM	20 Best-Selling Perfumes That Never Go Out of Style (Insider Monkey)
01:38PM	15 Best Beauty Stocks To Invest In (Insider Monkey)
Mar-24-24 06:33PM	20 Most Popular Female Perfume Brands in USA (Insider Monkey)
06:03PM	20 Highest Quality Unisex Perfumes in 2024 (Insider Monkey)
05:32PM	20 Best Feminine Perfumes For Everyday Use (Insider Monkey)
Mar-22-24 09:21AM	40 Best Perfumes for Women of 2024 (Insider Monkey)
Mar-20-24 05:24PM	Top Selling Feminine Fragrances in France : 20 Popular Perfumes (Insider Monkey)
05:06PM	20 Most Luxurious Feminine Perfumes in the World (Insider Monkey)
04:54PM	15 High Quality Foundations for All Skin Types (Insider Monkey)
Mar-19-24 10:00AM	Coty Wins this years Euronext Best listing Award in the Large Cap category (Business Wire)
08:24AM	Do You Think Cotys (COTY) Fundamentals Have Improved? (Insider Monkey)
Mar-13-24 10:25AM	15 Biggest Skincare Companies in the US (Insider Monkey)
Mar-11-24 08:40PM	Analyst Report: Coty Inc. (Morningstar Research)
Mar-08-24 11:30AM	Why Is Coty (COTY) Up 6.7% Since Last Earnings Report? (Zacks)
Mar-05-24 11:51AM	20 Highest Quality Perfumes in the World (Insider Monkey)
04:44PM	Loading…
Mar-04-24 04:44PM	Sally Hansen Partners With HERSHEYS KISSES Brand for an Indulgent New Nail Collection Almost Good Enough to Eat (Business Wire)
Mar-01-24 08:30AM	Calvin Klein Fragrances announces Idris and Sabrina Elba as the face of new Calvin Klein ETERNITY AROMATIC ESSENCE fragrance campaign (Business Wire)
01:00AM	Calvin Klein Fragrances Tap Idris, Sabrina Elba for Eternity Aromatic Essence Campaign (WWD)
Feb-29-24 01:43PM	Top Stock Movers Now: Hormel, Bath & Body Works, Best Buy, and More (Investopedia)
Feb-27-24 01:10AM	EXCLUSIVE: Infiniment Coty Paris Bridges the Past and Future (WWD)
Feb-23-24 03:33AM	25 Most Valuable Luxury Companies in the World (Insider Monkey)
Feb-22-24 04:30PM	Coty Completes First Phase of Share Buyback Program (Business Wire)
Feb-21-24 06:39PM	Analyst Report: Coty Inc. (Morningstar Research)
Feb-20-24 12:30AM	Coty to Update on Market Beating Progress, Outlook, and White-Space Opportunities at CAGNY 2024 Conference (Business Wire)
12:00AM	Coty and Etro Ink Long-term Beauty License (WWD)
12:00AM	Coty and Etro Embark on New License Agreement (Business Wire)
Feb-14-24 03:15AM	15 Beauty Treatments That Are Expensive But Totally Worth It (Insider Monkey)
Feb-12-24 02:02AM	20 Biggest Cosmetics Brands in the World (Insider Monkey)
Feb-08-24 11:50PM	Q2 2024 Coty Inc Earnings Call (Thomson Reuters StreetEvents)
04:45PM	Coty Announces Filing of Quarterly Report on Form 10-Q for the Fiscal Quarter Ended December 31, 2023 (Business Wire)
10:02AM	Analyst Report: Coty Inc. (Morningstar Research)
09:35AM	Coty Inc. (NYSE:COTY) Q2 2024 Earnings Call Transcript (Insider Monkey)
Feb-07-24 07:00PM	Coty (COTY) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:45PM	Coty (COTY) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:56PM	Coty Inc. (COTY) Reports Robust Q2 and 1H24 Earnings with Double-Digit Sales Growth (GuruFocus.com)
04:52PM	Coty: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:43PM	Coty Beats Wall Street Forecasts in Q2 (WWD)
04:36PM	Coty (NYSE:COTY) Q2: Beats On Revenue (StockStory)
04:30PM	Coty Delivers Strong Q2 and 1H24 Results with Growth Ahead of Beauty Market (Business Wire)
04:11PM	15 Highest Quality Makeup Brands In The World (Insider Monkey)
Feb-06-24 09:21AM	11 Best Hair Care Stocks To Buy Now (Insider Monkey)
08:56AM	Is a Surprise Coming for Coty (COTY) This Earnings Season? (Zacks)
08:00AM	Sally Hansen® Celebrates 10 Iconic Years of Miracle Gel With a Birthday Collection (Business Wire)
02:01AM	Coty (COTY) Q2 Earnings Report Preview: What To Look For (StockStory)
01:01AM	Coty Inks Beauty License Deal With Marni (WWD)
12:00AM	Coty and Marni Enter a New Beauty License (Business Wire)
Feb-05-24 09:16AM	Unveiling Coty (COTY) Q2 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Feb-02-24 09:35AM	Coty (COTY) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Feb-01-24 12:01AM	After Success in the German Market, Coty Renews Mexx & Bruno Banani Fragrance Licenses (WWD)
12:00AM	Coty renews long-term license partnership with bruno banani (Business Wire)
12:00AM	Coty Announces Extension of Its Licensing Partnership With Mexx (Business Wire)
Jan-31-24 10:00AM	Coty (COTY) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jan-03-24 06:40PM	Analyst Report: Coty Inc. (Morningstar Research) -5.48%
Jan-02-24 11:52AM	Sally Hansen® Launches Nail Art Decals to Customize Your Mani & Expands the Salon Effects® Franchise (Business Wire)
Dec-14-23 06:34PM	Analyst Report: Coty Inc. (Morningstar Research)
Dec-07-23 11:31AM	Coty (COTY) Up 15.2% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-06-23 09:52AM	15 Best Colognes for Men Under $50 (Insider Monkey)
Dec-01-23 06:19PM	Weekly Roundup (TheStreet.com)
09:00AM	Coty Inc. to Present at Several Upcoming Investor Events (Business Wire)
Nov-28-23 10:35AM	Cyber Monday rings in $12.4 billion in sales as consumers hunt for bargains (Yahoo Finance)
02:00AM	Coty Expands Global Parental Leave Policy in FY23 Sustainability Report (Business Wire)
Nov-22-23 12:30PM	Coty Inc. Announces Pricing of Cash Tender Offers and Acceptance of $400 Million Outstanding Debt Securities (Business Wire)
Nov-21-23 08:31PM	Coty Inc. Announces Early Results of Cash Tender Offers for Up to $400 Million Outstanding Debt Securities (Business Wire)
Nov-13-23 05:58PM	Coty Increases Share Repurchase Program by $600 Million to Accommodate Planned Hedged Share Buyback Transaction of Additional 25 Million Shares (Business Wire)
Nov-09-23 07:10PM	Coty Inc. (NYSE:COTY) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:03AM	Q1 2024 Coty Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-07-23 04:40PM	Coty Inc. Announces Cash Tender Offers for Up to $400 Million Outstanding Debt Securities (Business Wire)
04:30PM	Coty Delivers Very Strong Start to FY24 with Growth Ahead of Beauty Market (Business Wire)
Nov-03-23 07:15AM	COTY Set to Report Q1 Earnings: What Awaits the Stock? (Zacks)
Nov-02-23 11:44AM	Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance (Zacks)
Oct-18-23 10:38AM	COTY Rides On Solid Beauty Product Demand, Headwinds Persist (Zacks)
Oct-12-23 11:28AM	Insiders Are Betting Millions on These 2 Stocks Heres Why You Might Want to Follow Their Lead (TipRanks)
Oct-09-23 01:09PM	Hedge Fund and Insider Trading News: Nelson Peltz, Ken Griffin, Boaz Weinstein, Bill Ackman, Caius Capital, Two Sigma Advisors, Third Point LLC, Odey Asset Management, Coty Inc. (COTY), F&G Annuities & Life Inc (FG), and More (Insider Monkey)
Oct-07-23 05:02AM	Director Isabelle Parize Buys 20,500 Shares of Coty Inc (GuruFocus.com)
Oct-03-23 01:31PM	Hedge Fund and Insider Trading News: Ray Dalio, David Einhorn, Sculptor Capital Management, Balyasny Asset Management, Bain Capital, Coty Inc (COTY), Howard Hughes Holdings Inc (HHH), and More (Insider Monkey)
Sep-28-23 10:45AM	COTY Shares Increase 28.7% YTD: What's Driving the Stock? (Zacks)
07:09AM	Coty Inc. Announces Pricing of Global Offering and Admission to Listing and Trading of Class A Common Stock on the Professional Segment of Euronext Paris (Business Wire)
Sep-27-23 01:03PM	Decoding Coty Inc (COTY)'s Performance Potential: A Deep Dive into Key Metrics (GuruFocus.com)
Sep-26-23 12:10PM	Stocks to Watch Tuesday: Amazon.com, DraftKings, JD.com, Costco (The Wall Street Journal)
11:54AM	Unveiling Coty (COTY)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
09:50AM	Coty launches global offering of 33 million shares, eyes Paris listing (Yahoo Finance Video)
06:39AM	Beauty Company Coty Offers 33 Million Shares Ahead of Paris Listing (Bloomberg)
Sep-25-23 04:27PM	Coty Inc. Launches Global Offering of Class A Common Stock and Listing on the Professional Segment of Euronext Paris (Business Wire)
Sep-22-23 10:35AM	COTY's Listing Plans in Paris Look Good: Things Worth Noting (Zacks)
05:01AM	US Beauty Firm Coty to Move Forward With Paris Share Sale (Bloomberg)

Coty, Inc. engages in the manufacture, market, sale, and distribution of branded beauty products. It operates through the following segments: Prestige, Consumer Beauty, and Corporate. The company was founded by Francois Coty in 1904 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Singer Robert S	Director	Mar 06 '24	Sale	12.70	30,000	380,877	120,000	Mar 06 06:44 PM
Singer Robert S	Director	Mar 06 '24	Sale	12.72	20,000	254,364	121,500	Mar 06 06:44 PM
Singer Robert S	Director	Mar 05 '24	Sale	12.60	19,982	251,849	150,000	Mar 06 06:44 PM
Singer Robert S	Director	Mar 04 '24	Sale	12.56	90,000	1,130,058	169,982	Mar 06 06:44 PM
Goudet Olivier	Director	Nov 15 '23	Option Exercise	0.00	10,000	0	10,000	Nov 17 04:59 PM
HARF PETER	Director	Nov 15 '23	Option Exercise	0.00	10,000	0	40,000	Nov 17 04:54 PM
Singer Robert S	Director	Nov 15 '23	Option Exercise	0.00	10,000	0	259,982	Nov 17 04:52 PM
Mercier Laurent	Chief Financial Officer	Oct 19 '23	Option Exercise	0.00	156,745	0	302,157	Oct 23 06:21 PM
Parize Isabelle	Director	Oct 09 '23	Buy	10.50	4,775	50,138	61,500	Oct 10 04:23 PM
Parize Isabelle	Director	Oct 04 '23	Buy	10.29	20,500	210,945	56,725	Oct 06 09:06 PM
JAB Holdings B.V.	10% Owner	Oct 02 '23	Buy	10.80	3,000,000	32,400,000	451,853,684	Oct 04 07:23 PM
ARAMBURUZABALA MARIA ASUNICION	Director	Sep 28 '23	Buy	10.80	500,000	5,400,000	1,425,000	Oct 02 04:29 PM
Zafar Ayesha	SVP Group Controller	Sep 04 '23	Option Exercise	0.00	4,699	0	103,665	Sep 25 08:59 AM
Mercier Laurent	Chief Financial Officer	Sep 04 '23	Option Exercise	0.00	4,699	0	145,412	Sep 25 08:59 AM
Nabi Sue	Chief Executive Officer	Aug 31 '23	Option Exercise	0.00	10,000,000	0	30,304,786	Sep 01 07:49 PM
von Bretten Gordon	Chief Transformation Officer	Jun 05 '23	Option Exercise	0.00	230,984	0	736,259	Sep 25 08:56 AM

Open in Screener

GSK

GSK Plc ADR

Apr 26 • 01:42PM ET

41.28

Dollar change +0.37
Percentage change 0.90	%

Healthcare • Drug Manufacturers - General • United Kingdom • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Index	-	P/E	13.80	EPS (ttm)	2.99	Insider Own	0.01%	Shs Outstand	2.03B	Perf Week	3.85%
Market Cap	83.76B	Forward P/E	9.41	EPS next Y	4.39	Insider Trans	0.00%	Shs Float	2.03B	Perf Month	-3.98%
Income	6.13B	PEG	2.87	EPS next Q	0.92	Inst Own	14.98%	Short Float	0.36%	Perf Quarter	5.66%
Sales	37.73B	P/S	2.22	EPS this Y	-1.94%	Inst Trans	0.60%	Short Ratio	2.11	Perf Half Y	14.51%
Book/sh	8.39	P/B	4.92	EPS next Y	13.20%	ROA	8.31%	Short Interest	7.35M	Perf Year	14.89%
Cash/sh	3.26	P/C	12.68	EPS next 5Y	4.80%	ROE	41.19%	52W Range	33.33 - 43.84	Perf YTD	11.39%
Dividend Est.	1.52 (3.69%)	P/FCF	13.45	EPS past 5Y	4.23%	ROI	16.84%	52W High	-5.84%	Beta	0.67
Dividend TTM	1.47 (3.55%)	Quick Ratio	0.62	Sales past 5Y	-1.06%	Gross Margin	70.52%	52W Low	23.85%	ATR (14)	0.56
Dividend Ex-Date	Feb 22, 2024	Current Ratio	0.88	EPS Y/Y TTM	-64.86%	Oper. Margin	22.97%	RSI (14)	52.44	Volatility	1.37% 1.25%
Employees	70212	Debt/Eq	1.35	Sales Y/Y TTM	-4.87%	Profit Margin	16.25%	Recom	2.36	Target Price	46.74
Option/Short	Yes / Yes	LT Debt/Eq	1.14	EPS Q/Q	-75.40%	Payout	47.48%	Rel Volume	0.54	Prev Close	40.91
Sales Surprise	6.12%	EPS Surprise	0.08%	Sales Q/Q	15.46%	Earnings	May 01 BMO	Avg Volume	3.48M	Price	41.28
SMA20	1.03%	SMA50	-1.29%	SMA200	8.89%	Trades		Volume	1,253,696	Change	0.90%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight
Dec-05-22	Downgrade	BofA Securities	Neutral → Underperform
Nov-11-22	Downgrade	UBS	Neutral → Sell
Sep-15-22	Upgrade	Credit Suisse	Underperform → Neutral
Sep-08-22	Downgrade	Jefferies	Buy → Hold	$50.50 → $34
Aug-05-22	Resumed	Morgan Stanley	Equal-Weight
Jul-21-22	Resumed	Citigroup	Neutral
Feb-11-22	Downgrade	DZ Bank	Buy → Hold
Nov-05-21	Upgrade	Barclays	Underweight → Equal Weight
Jun-24-21	Upgrade	Deutsche Bank	Sell → Hold
Mar-23-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Feb-04-21	Downgrade	Deutsche Bank	Hold → Sell

Show Previous Ratings

Apr-25-24 01:30PM	CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript (Insider Monkey)
11:34AM	20 Fastest Growing Health Tech Companies in the World (Insider Monkey)
09:54AM	UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology (Reuters)
09:39AM	GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology (Reuters)
08:52AM	US FDA accepts sBLA for GSK's Jemperli for broader endometrial cancer use (Pharmaceutical Business Review)
10:01AM	Loading…
Apr-24-24 10:01AM	GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-17-24 09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
Apr-16-24 11:52AM	14 Cheap Penny Stocks to Buy According to Analysts (Insider Monkey)
Apr-11-24 05:50PM	GSK (GSK) Rises But Trails Market: What Investors Should Know (Zacks)
Apr-06-24 08:47PM	10 Best Weight Loss Drug Stocks to Buy Now (Insider Monkey)
Apr-05-24 06:00PM	GSK (GSK) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
05:52PM	Health Care Roundup: Market Talk (The Wall Street Journal)
Mar-28-24 09:00AM	GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-27-24 09:17PM	UPDATE 1-U.S. FDA approves Akebia's anemia drug (Reuters)
Mar-26-24 06:15PM	GSK (GSK) Stock Moves -0.09%: What You Should Know (Zacks)
09:53AM	Loading…
09:53AM	WuXi Biologics Reports Solid 2023 Annual Results (PR Newswire)
05:10AM	32 Countries with the Highest Rates of Diabetes (Insider Monkey)
Mar-24-24 03:54PM	12 Best Biotech Penny Stocks to Invest In (Insider Monkey)
03:23AM	Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead? (Motley Fool)
Mar-22-24 10:54AM	After GSK acquisition, Bellus CEO seeks work opportunities for displaced staff (FierceBiotech.com)
Mar-19-24 06:00PM	GSK (GSK) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
12:19PM	Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale (The Wall Street Journal)
10:31AM	Pfizer Sells $3.5 Billion of Shares in Haleon (Bloomberg)
Mar-18-24 03:06PM	Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow? (The Wall Street Journal)
09:20AM	ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:09AM	AlTi Global, Inc. (NASDAQ:ALTI) Q4 2023 Earnings Call Transcript (Insider Monkey)
05:17AM	Pfizer Plans to Sell About £2 Billion of Shares in Haleon (Bloomberg)
Mar-16-24 08:00AM	Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer (Business Wire)
Mar-15-24 12:51PM	Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-14-24 09:38AM	12 Most Profitable Biotech Stocks To Invest In (Insider Monkey)
09:00AM	Loading…
09:00AM	GSK PLC Sponsored ADR (GSK) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Mar-13-24 09:40AM	Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year? (Zacks)
Mar-12-24 10:20AM	Global Contraceptive Drugs Market Size is Projected to Reach USD 28.96 billion by 2030, Growing at a CAGR of 7.3%: Straits Research (GlobeNewswire)
Mar-09-24 10:06AM	10 New Alternatives to Antibiotics: Alternative Therapeutic Strategies to Treat Antibiotic-Resistant Pathogens (Insider Monkey)
Mar-07-24 12:00PM	GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise (Business Wire)
08:24AM	Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-06-24 08:03AM	UK NICE recommends GSK's Dostarlimab regimen for womb cancer (Pharmaceutical Business Review)
Mar-05-24 02:56AM	13 Best Pharma Dividend Stocks To Buy in 2024 (Insider Monkey)
Mar-01-24 11:30AM	Glaxo (GSK) Up 3.1% Since Last Earnings Report: Can It Continue? (Zacks)
09:00AM	Once a Hot Stock-Market Trend Has a Name, Its Best Days Are Likely Past (The Wall Street Journal)
Feb-29-24 04:37PM	Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results (GuruFocus.com)
09:00AM	Investors Heavily Search GSK PLC Sponsored ADR (GSK): Here is What You Need to Know (Zacks)
02:52AM	Haleon Backs Views After Profit Rise on Robust Growth (The Wall Street Journal)
Feb-28-24 09:50AM	Here's Why GSK (GSK) is a Strong Momentum Stock (Zacks)
Feb-27-24 09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
Feb-26-24 12:00PM	All You Need to Know About Glaxo (GSK) Rating Upgrade to Buy (Zacks)
09:40AM	Are Medical Stocks Lagging GSK PLC Sponsored ADR (GSK) This Year? (Zacks)
05:49AM	GSK, pushing back UTI filing by a year, shows antibiotic's gonorrhea potential in phase 3 (FierceBiotech.com)
Feb-23-24 05:12AM	GSK, Vir end flu drug alliance, removing key piece of $345M pact (FierceBiotech.com)
Feb-22-24 11:22AM	Moderna CEO: 2024 is year of growth, with 2023 transition in rearview (Yahoo Finance)
11:00AM	Moderna Is Pivoting From Covidthe Results Are on Their Way (The Wall Street Journal)
06:10AM	Move Over Magnificent 7, Say Hello to the GRANOLAS (InvestorPlace)
Feb-21-24 05:02AM	GSK PLC's Dividend Analysis (GuruFocus.com)
Feb-14-24 09:17AM	GSK still has a crush on oligonucleotides, sealing the deal with Elsie (FierceBiotech.com)
Feb-12-24 09:50AM	Why GSK (GSK) is a Top Momentum Stock for the Long-Term (Zacks)
Feb-10-24 08:30AM	30 Most Valuable Drug Companies in 2024 (Insider Monkey)
Feb-09-24 02:35PM	Moderna's stock slumps after RSV shot efficacy wanes faster than GSK's Arexvy (FierceBiotech.com)
Feb-08-24 07:00AM	Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer's Disease (GlobeNewswire)
Feb-07-24 04:01PM	23andMe Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
07:00AM	FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) (GlobeNewswire)
Feb-06-24 07:00AM	GSKs RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased Risk (Business Wire)
06:15AM	The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024 (InvestorPlace)
Feb-05-24 09:45PM	UPDATE 1-US bill poses risk to Wuxi AppTec and its Western drugmaker partners (Reuters)
08:45PM	Lightning Round: I'm a believer in GSK, it could go higher, says Jim Cramer (CNBC TV)
06:02AM	US bill poses risk to Wuxi AppTec and its Western drugmaker partners (Reuters)
Feb-02-24 04:30PM	23andMe is low on cash and its stock is worth pennies. The CEO wants another chance (CNN Business)
Feb-01-24 05:14PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:46AM	GSK plc (NYSE:GSK) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:46AM	Drugmaker Abbott India's Q3 profit rises on strong demand (Reuters)
Jan-31-24 05:05PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:59PM	Tech, Media & Telecom Roundup: Market Talk (The Wall Street Journal)
02:50PM	Analyst Report: GSK plc (Morningstar Research)
12:50PM	Novo Nordisk Tops $500 Billion Valuation; Ozempic, Wegovy Fuel Earnings (The Wall Street Journal)
11:00AM	Novo Nordisk Earnings Top Forecasts, Fueled by Ozempic, Wegovy Sales (The Wall Street Journal)
10:50AM	GSK Upgrades Long-Term Outlook After Q4 Performance, Shingrix Vaccine And Newly Launched RSV Vaccine Shine (Benzinga)
07:31AM	GSK tips 12 blockbuster launches to soften HIV patent loss, power sales toward $50B (FierceBiotech.com)
07:05AM	GSK (GSK) Misses Q4 Earnings Estimates (Zacks)
02:54AM	GSK Bets on Further Growth After Shingles and RSV Vaccines Boost Sales (The Wall Street Journal)
02:27AM	GSK Sales Rose on Shingles Vaccine Growth, RSV Drug Launch (The Wall Street Journal)
Jan-29-24 02:03PM	After GSK and Novartis handoffs, Laekna's drug fails ovarian cancer trial (FierceBiotech.com)
01:39AM	Novo Nordisk Puts Pharma Peers in the Shade as Key Earnings Reports Awaited (Bloomberg)
Jan-25-24 01:06PM	The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs (InvestorPlace)
09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
Jan-24-24 10:08AM	Private equity firm Yellow Wood close to deal to acquire ChapStick-sources (Reuters)
10:00AM	GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:00AM	Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegens Cell-Free DNA Production Technology (Business Wire)
05:36AM	The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs (InvestorPlace)
Jan-23-24 08:00AM	Warren Buffett used to think that 'predicting' the stock market was the most important thing in investing until 1 book changed his life forever. Here's the real key to long-term gains (Moneywise)
Jan-21-24 08:27AM	5 Most Profitable New Stocks Today (Insider Monkey)
Jan-18-24 02:41PM	Drugmakers Raise Prices of Ozempic, Mounjaro and Hundreds of Other Drugs (The Wall Street Journal)
Jan-09-24 01:49PM	GSK Boosts Respiratory Portfolio with $1.4 Billion Aiolos Bio Acquisition (Investopedia)
01:14PM	Stocks to Watch Tuesday: Boeing, Match, HPE, JetBlue (The Wall Street Journal)
12:32PM	Health Care Roundup: Market Talk (The Wall Street Journal)
05:52AM	GSK Enters Agreement to Acquire Aiolos Bio (Business Wire)
05:11AM	GSK, moving fast to buy Aiolos, pays $1B to challenge Amgen, AstraZeneca for asthma market (FierceBiotech.com)
03:07AM	GSK Expands Respiratory Pipeline With Aiolos Bio Buy (The Wall Street Journal)
02:49AM	JPM24, Day 2: GSK gets in on the M&A action (FierceBiotech.com)
02:35AM	GSK Buys Aiolos Bio for Up to $1.4 Bln (The Wall Street Journal)
Jan-08-24 08:18PM	Analyst Report: GSK plc (Morningstar Research)
06:58AM	Curevo's shingles vaccine equals GSK's Shingrix in phase 2 head-to-head (FierceBiotech.com)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GSK plc	10% Owner	Dec 07 '23	Buy	5.00	3,300,000	16,500,000	13,983,761	Jan 30 04:39 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

COTY

Coty Inc

GSK

GSK Plc ADR

Upgrade your FINVIZ experience